Drug
Laboratory Biomarker Analysis
Laboratory Biomarker Analysis: highest development phase Phase 2, developed by Bristol-Myers Squibb. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Bristol-Myers Squibb
Trials
| Drug | Phase | Indication |
|---|---|---|
| Laboratory Biomarker Analysis NCT03333746 | Phase 2 | Recurrent Plasma Cell Myeloma |
Latest
No recent events.
Follow Laboratory Biomarker Analysis on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.